InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (123)	8/14/2001 9:32:09 AM
From: IRWIN JAMES FRANKEL	of 508

That is quite a "hint". If Infergen were pegylated (now that ribavirin is unbundled) it would be a serious competitor to Intron A. The PR raises the potential of pegylating Actimunne. Anyone have a feel for how important an improvement that would be theraputically? ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next